• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 2 fuera de 10 páginas
Examen

NR565/ NR 565 Pharmacology Midterm (Latest 2026/2027 Update) | Exam Questions with Verified Answers and Detailed Rationales | Comprehensive Q&A – Pharmacokinetics, Drug Interactions, Controlled Substances, Special Populations | A+ Graded | Chamberlain Uni

Document preview thumbnail
Vista previa 2 fuera de 10 páginas

INSTANT PDF DOWNLOAD - This is the comprehensive Midterm Exam study guide for NR565 Advanced Pharmacology Fundamentals at Chamberlain University (Latest 2026/2027 Update), featuring 100% verified questions and answers with detailed rationales. Covers pharmacokinetics across the lifespan, CYP450 enzyme inducers/inhibitors, controlled substance regulations, APRN prescriptive authority, pregnancy medication safety, geriatric pharmacology, and medication management in special populations. INSTANT DIGITAL DOWNLOAD (PDF) immediately upon purchase. Fully text-searchable, printable, and accessible anytime. Trusted by Chamberlain FNP students for Midterm success. 100% satisfaction guarantee. NR565 Pharmacology Midterm Chamberlain NR 565 Advanced Pharmacology Midterm Pharmacokinetics Absorption Distribution Metabolism Excretion CYP450 Inducers Rifampin Phenytoin St Johns Wort CYP450 Inhibitors Ketoconazole Grapefruit Juice Amiodarone Controlled Substances Schedule II III IV V APRN Prescriptive Authority State Boards Geriatric Pharmacology Decreased Renal Function Neonatal Pharmacology Slow IM Absorption Pregnancy Teratogenic Medications First Trimester Chamberlain NR565 Test Bank NR565 Midterm A+ Graded Pharmacology Study Guide

Vista previa del contenido

NR 565 Advanced Pharmacology Midterm Exam: (Latest 2025/2026 Update)
Comprehensive Q&A | Grade A | 100% Correct (Verified Answers) – Nursing
Program

Subject: Advanced Pharmacology (NR 565) – Midterm Exam: Pharmacogenomics, Drug Schedules,
Neuropharmacology, Psychiatric Medications, Clinical Trials, Cardiovascular/Rheumatologic Agents
Source: Midterm Blueprint – CYP450, Antidepressants, Antipsychotics, Anticonvulsants, Pain
Management, Autonomic Pharmacology, Clinical Phases
Format: Q&A Guide with Rationale – 100% Verified Answers
Verified: Latest 2025/2026 Update | Grade A Guaranteed


1: What is the clinical significance of CYP2D6 poor metabolizer status?
Correct Answer: Need to increase doses of SSRIs, beta blockers, etc.; codeine can be deadly (poor
conversion to morphine)

1. CYP2D6 metabolizes many psychiatric and cardiovascular drugs.
2. Poor metabolizers have reduced enzyme activity → higher drug levels, increased side effects.
3. Codeine requires CYP2D6 conversion to morphine; poor metabolizers get little analgesia;
ultrarapid metabolizers risk toxicity/death.

2: What is the clinical significance of CYP2C9 polymorphism regarding warfarin?
Correct Answer: Decrease warfarin dose; test for VKORC1 mutation

1. CYP2C9 metabolizes warfarin (S-enantiomer).
2. Variants (CYP2C9*2, *3) reduce metabolism → increased bleeding risk; lower starting doses
recommended.
3. VKORC1 genotype also affects warfarin sensitivity.

3: What is the effect of CYP3A4 inhibition on amiodarone?
Correct Answer: Decreases elimination, increases toxicity of amiodarone

1. CYP3A4 metabolizes amiodarone.
2. Inhibitors (grapefruit juice, ketoconazole, erythromycin) increase amiodarone levels → toxicity
(pulmonary fibrosis, hepatotoxicity, thyroid dysfunction).
3. Avoid strong inhibitors or reduce amiodarone dose.

4: Describe Schedule I controlled substances.
Correct Answer: No accepted medical use in the US; may not be prescribed. Examples: heroin, various
opium derivatives, hallucinogenic substances (LSD, ecstasy, peyote)

1. Schedule I has highest abuse potential and no approved medical use.
2. Research use requires special DEA registration.
3. Marijuana remains Schedule I federally despite state legalization.

, 5: Describe Schedule II controlled substances.
Correct Answer: No refills, no telephone orders (emergency orders allowed with written follow-up
within 72 hours). Narcotics, stimulants, depressants. Examples: oxycodone, fentanyl, Adderall, Ritalin,
methadone.

1. Schedule II has high abuse potential with severe psychological/physical dependence.
2. Prescriptions must be written or electronic; cannot be called in except emergencies.
3. Multiple prescriptions on same day allowed under certain conditions.

6: Describe Schedule III controlled substances.
Correct Answer: Moderate or low risk for physical dependence; current medical use. Examples:
anabolic steroids, most barbiturates, ketamine, Tylenol with codeine (<90mg). Must prescribe every 6
months; can be by phone; up to 5 refills within 6 months.

1. Schedule III has lower abuse potential than Schedule II.
2. Prescriptions valid for 6 months from date written.
3. Abuse potential less than I/II but greater than IV.

7: Describe Schedule IV controlled substances.
Correct Answer: Abuse potential exists but less than Schedule III. Examples: Ambien (zolpidem),
Darvocet, lorazepam, alprazolam, diazepam, tramadol.

1. Schedule IV has low abuse potential and low risk of dependence.
2. Same prescription/refill rules as Schedule III (up to 5 refills within 6 months).
3. Benzodiazepines are Schedule IV.

8: Describe Schedule V controlled substances.
Correct Answer: Lowest abuse potential; not always necessary to have a prescription. Examples:
loperamide, diphenoxylate, cough medicine with less than 200mg codeine/100mL, pregabalin (Lyrica).

1. Schedule V have accepted medical use and limited abuse potential.
2. Lyrica (pregabalin) is Schedule V – used for neuropathic pain, fibromyalgia, seizures.
3. Some states allow pharmacist dispensing without prescription for certain Schedule V.

9: What occurs during preclinical research phase?
Correct Answer: Research of drug potential, animal testing, preparation for human testing

1. Preclinical phase assesses safety, efficacy, and pharmacokinetics in animals.
2. Identifies potential toxicities before first-in-human studies.
3. Results submitted to FDA as Investigational New Drug (IND) application.

10: What occurs during Phase I clinical trials?
Correct Answer: Initial clinical safety studies in humans; may be as few as 10 subjects, often healthy
volunteers. Determines safe dosage range, pharmacokinetics, and side effects.

1. Phase I trials typically last several months.
2. 70-80% of drugs move to Phase II.
3. Assesses maximum tolerated dose and dose-limiting toxicities.

Información del documento

Subido en
17 de mayo de 2026
Número de páginas
10
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$12.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
DoctorKen
3.8
(167)
Vendido
921
Seguidores
121
Artículos
6650
Última venta
5 horas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes